Skip to main content
Dhanuka Agritech Ltd. logo

Dhanuka Agritech Ltd. — Investor Relations & Filings

Ticker · DHANUKA ISIN · INE435G01025 LEI · 335800E4DLZIC7MSG125 BSE.NS Manufacturing
Open in API
Filings indexed 1,595 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country IN India
Listing BSE.NS DHANUKA

About Dhanuka Agritech Ltd.

https://www.dhanuka.com/

Dhanuka Agritech Ltd. specializes in the manufacturing and marketing of a comprehensive range of crop protection solutions, including insecticides, herbicides, fungicides, and plant growth regulators. The company maintains strategic technical collaborations with several global chemical innovators to bring advanced formulations to the agricultural sector. Its product portfolio is supported by a robust research and development infrastructure and an extensive distribution network that facilitates the delivery of integrated pest management and soil health solutions. The organization focuses on enhancing agricultural productivity through the provision of high-quality inputs and technical advisory services. By leveraging a strong field force, it provides training and support to optimize crop yields and resource efficiency, ensuring the effective application of its diverse chemical and biological offerings.

Recent filings

Filing Released Lang Actions
Board approves Final Dividend @100% i.e. Rs. 2 each
Regulatory Filings Classification · 90% confidence The document is the formal outcome of a Board Meeting filed under SEBI (LODR) Regulations and includes multiple corporate actions: audited financial results, auditor’s report, ESOP/SAR adoption, buyback proposal, dividend recommendation, AGM convening, management retirements, cost auditor reappointment, overseas subsidiaries approval, etc. It is not a full Annual Report or standalone Interim Report, nor is it solely an earnings release or dividend notice. It is a regulatory disclosure under the Listing Regulations (“Regulation 30/33”) and serves as a general compliance announcement. Therefore, it falls into the fallback category of Regulatory Filings (RNS).
2026-05-19 English
Board Approves Buyback
Earnings Release Classification · 86% confidence The document is a formal SEBI Listing Regulations board meeting outcome announcing and enclosing the audited financial results for the quarter and financial year ended March 31, 2026 along with the Statutory Auditor’s Report. This constitutes the initial public announcement of period financial results rather than the full annual report itself. There are also related corporate actions (ESOP adoption, buyback proposal, dividend recommendation, AGM notice) but the central disclosure is the audited results announcement. This aligns with the definition of an Earnings Release (ER). FY 2026
2026-05-19 English
Outcome of Board Meeting
Regulatory Filings Classification · 78% confidence The document is a stock exchange filing under SEBI Listing Regulations summarizing the outcomes of the Board Meeting held on May 19, 2026 (approval of audited financial results, ESOP/SAR plans, buyback proposal, dividend, AGM convening, management retirements, cost auditor re-appointment, overseas subsidiary approvals, etc.). It does not contain the full annual report or the detailed audited statements themselves, nor is it a simple earnings release or call transcript. Rather, it is a regulatory announcement of board resolutions and miscellaneous compliance disclosures – i.e., a general regulatory filing. Therefore it is best classified as Regulatory Filings (RNS).
2026-05-19 English
Audited Financial Results For The Quarter and Financial Year Ended 31st March 2026
Regulatory Filings Classification · 85% confidence The document is the “Outcome of the Board Meeting” notice filed under SEBI (Listing Obligations and Disclosure Requirements) Regulations to the stock exchanges. It covers multiple board approvals (audited results, ESOP/SAR plans, buyback proposal, dividend, AGM notice, retirement of senior management, cost auditor appointment, overseas subsidiaries) and includes the auditor’s report on the financial results. It is a general regulatory announcement rather than the full Annual Report or a simple earnings press release. It is therefore classified as a general regulatory filing (RNS).
2026-05-19 English
Intimation with respect to Conference Call with Analysts/ Investors to discuss Audited Financial Results of the Company for the Quarter and Financial Year Ended on 31st March 2026
Regulatory Filings Classification · 90% confidence The document is a formal stock exchange disclosure (under Regulation 30 of SEBI LODR) notifying the listing authorities and investors of a scheduled conference call to discuss audited financial results. It contains no actual financial data, slides, or transcript—only a notice of the event. It does not fit into Earnings Release (ER) since no results are published, nor Call Transcript (CT) since it's not a transcript. It is therefore a general regulatory announcement and falls under Regulatory Filings (RNS).
2026-05-14 English
Dhanuka Agritech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results ....
Regulatory Filings Classification · 75% confidence The document is a formal notice to the stock exchanges under SEBI (Listing Obligation and Disclosure Requirements) Regulation 29 announcing a Board meeting date and agenda items. It does not present actual financial statements, changes in management, voting results, or call transcripts, nor is it a publication of a report itself. It is a mandated regulatory announcement and therefore falls under the general “Regulatory Filings” category (RNS).
2026-05-14 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.